Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.11
+0.07 (0.99%)
Apr 1, 2025, 3:49 PM EDT - Market open
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lifecore Biomedical stock have an average target of 8.00, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 12.52% from the current stock price of 7.11.
Analyst Consensus: Buy
* Price targets were last updated on Jan 3, 2025.
Analyst Ratings
The average analyst rating for Lifecore Biomedical stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | -15.61% | Jan 3, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +40.65% | Nov 22, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +12.52% | Sep 5, 2024 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 28, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +40.65% | Sep 1, 2023 |
Financial Forecast
Revenue This Year
131.01M
from 128.26M
Increased by 2.14%
Revenue Next Year
140.64M
from 131.01M
Increased by 7.35%
EPS This Year
-0.95
from 0.32
EPS Next Year
-0.65
from -0.95
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 136.4M | 149.4M | 165.1M | |
| Avg | 131.0M | 140.6M | 156.8M | |
| Low | 124.5M | 130.8M | 147.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.3% | 14.0% | 17.4% | |
| Avg | 2.1% | 7.4% | 11.5% | |
| Low | -2.9% | -0.1% | 4.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.93 | -0.63 | -0.42 |
| Avg | -0.95 | -0.65 | -0.41 |
| Low | -0.96 | -0.67 | -0.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.